PAVmed Shares Informal Financial Performance Insights
PremiumCompany AnnouncementsPAVmed Shares Informal Financial Performance Insights
1M ago
PAVmed Provides Business Update and Second Quarter 2024 Financial Results
Premium
Press Releases
PAVmed Provides Business Update and Second Quarter 2024 Financial Results
1M ago
PAVmed reports Q2 adjusted EPS (84c), consensus ($1.45)
Premium
The Fly
PAVmed reports Q2 adjusted EPS (84c), consensus ($1.45)
1M ago
Lucid Diagnostics announces data from ESOGUARD BE-1 study of EsoGuard
PremiumThe FlyLucid Diagnostics announces data from ESOGUARD BE-1 study of EsoGuard
3M ago
PAVmed Inc Provides Informal Financial Performance Update
Premium
Company Announcements
PAVmed Inc Provides Informal Financial Performance Update
4M ago
PAVmed Provides Business Update and First Quarter 2024 Financial Results
Premium
Press Releases
PAVmed Provides Business Update and First Quarter 2024 Financial Results
4M ago
PAVmed price target lowered to $4 at Lake Street
PremiumThe FlyPAVmed price target lowered to $4 at Lake Street
6M ago
PAVmed reports Q4 EPS ($1.33), two estimates ($1.79)
Premium
The Fly
PAVmed reports Q4 EPS ($1.33), two estimates ($1.79)
6M ago
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
Premium
Press Releases
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100